{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:54:38Z","timestamp":1760550878776,"version":"3.44.0"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.diabres.2019.07.005","type":"journal-article","created":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T11:14:39Z","timestamp":1562238879000},"page":"107781","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Non-albuminuric reduced eGFR phenotype in children and adolescents with type 1 diabetes"],"prefix":"10.1016","volume":"155","author":[{"given":"Procolo","family":"Di Bonito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enza","family":"Mozzillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco Maria","family":"Rosanio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Casertano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Fattorusso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Franzese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2019.07.005_b0005","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2337\/dc13-1870","article-title":"Microalbuminuria as a risk predictor in diabetes: the continuing saga","volume":"37","author":"Bakris","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2019.07.005_b0010","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2337\/dc11-1380","volume":"35","author":"Solini","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2019.07.005_b0015","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1007\/s00125-018-4691-2","article-title":"Renal insufficiency and cardiovascular events (RIACE) study group. Non-albuminuric renal impairment is a strong predictor of mortality in individuals with type 2 diabetes: the renal insufficiency and cardiovascular events (RIACE) Italian multicentre study","volume":"61","author":"Penno","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2019.07.005_b0020","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2337\/dc13-0985","article-title":"Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria","volume":"37","author":"Krolewski","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2019.07.005_b0025","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1007\/s00125-017-4251-1","article-title":"Evidence for two distinct phenotypes of chronic kidney disease in individuals with type 1 diabetes mellitus","volume":"60","author":"Penno","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2019.07.005_b0030","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.2337\/dc09-1098","volume":"33","author":"Molitch","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2019.07.005_b0035","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.2337\/dc16-0950","article-title":"Patterns of estimated glomerular filtration rate decline leading to end-stage renal disease in type 1 diabetes","volume":"39","author":"Skupien","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2019.07.005_b0040","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD","volume":"20","author":"Schwartz","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 27","key":"10.1016\/j.diabres.2019.07.005_b0045","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/pedi.12742","article-title":"ISPAD clinical practice consensus guidelines 2018: Microvascular and macrovascular complications in children and adolescents","volume":"19","author":"Donaghue","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.diabres.2019.07.005_b0050","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group: KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3(1):1-150. https:\/\/kdigo.org\/wp-content\/uploads\/2017\/02\/KDIGO_2012_CKD_GL.pdf."},{"key":"10.1016\/j.diabres.2019.07.005_b0060","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1007\/s00125-003-1194-5","article-title":"Diabetic nephropathy is associated with low-grade inflammation in type 1 diabetic patients","volume":"46","author":"Saraheimo","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2019.07.005_b0065","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.diabres.2018.07.031","article-title":"Glycemic control and microvascular complications in adults with type 1 diabetes and long-lasting treated celiac disease: a case-control study","volume":"143","author":"Creanza","year":"2018","journal-title":"Diabetes Res Clin Pract"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822719307776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822719307776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:07:48Z","timestamp":1759172868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822719307776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":12,"alternative-id":["S0168822719307776"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2019.07.005","relation":{},"ISSN":["0168-8227"],"issn-type":[{"type":"print","value":"0168-8227"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-albuminuric reduced eGFR phenotype in children and adolescents with type 1 diabetes","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2019.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107781"}}